Alligator Bioscience AB
STO:ATORX

Watchlist Manager
Alligator Bioscience AB Logo
Alligator Bioscience AB
STO:ATORX
Watchlist
Price: 3.971 SEK 1.82% Market Closed
Market Cap: 67.1m SEK

Wall Street
Price Targets

ATORX Price Targets Summary
Alligator Bioscience AB

Wall Street analysts forecast ATORX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATORX is 30.6 SEK with a low forecast of 30.3 SEK and a high forecast of 31.5 SEK.

Lowest
Price Target
30.3 SEK
663% Upside
Average
Price Target
30.6 SEK
671% Upside
Highest
Price Target
31.5 SEK
693% Upside
Alligator Bioscience AB Competitors:
Price Targets
PEB
Pacific Edge Ltd
19% Downside
HALO
Halozyme Therapeutics Inc
30% Upside
VCEL
Vericel Corp
58% Upside
IVACC
Intervacc AB
576% Upside
301207
Hualan Biological Bacterin Inc
19% Upside
CVAC
CureVac NV
55% Upside
GNFT
Genfit SA
150% Upside
ORY
Oryzon Genomics SA
182% Upside

Revenue
Forecast

Revenue Estimate
Alligator Bioscience AB

For the last 8 years the compound annual growth rate for Alligator Bioscience AB's revenue is 0%. The projected CAGR for the next 2 years is 17%.

0%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Alligator Bioscience AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Alligator Bioscience AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-90%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATORX's stock price target?
Price Target
30.6 SEK

According to Wall Street analysts, the average 1-year price target for ATORX is 30.6 SEK with a low forecast of 30.3 SEK and a high forecast of 31.5 SEK.

What is Alligator Bioscience AB's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Alligator Bioscience AB's revenue is 0%. The projected CAGR for the next 2 years is 17%.

Back to Top